Introduction
Sham ownership in Turkish pharmacy law, known in Turkish as eczane muvazaası, is one of the most serious legal risks in the pharmacy sector. A pharmacy in Turkey is not an ordinary retail business that can be freely owned by any investor, company or non-pharmacist. It is a regulated healthcare institution that must be opened and operated under the personal and professional responsibility of a legally qualified pharmacist. For this reason, Turkish law strictly prohibits structures where the official pharmacist appears as the owner on paper, while the real economic or managerial control belongs to another person.
Under Law No. 6197 on Pharmacists and Pharmacies, pharmacy is defined as a healthcare service involving the preparation and supply of medicines, monitoring of pharmacological effect, safety and efficacy, quality assurance, patient information and reporting of medicine-related problems. The law also states that opening and operating a pharmacy requires being a pharmacist.
This pharmacist-centered model is the legal foundation of the anti-muvazaa regime. If a pharmacy is opened through sham ownership, the issue is not merely a private contractual defect. It becomes a public health, professional ethics, licensing and administrative law problem. The Regulation on Pharmacists and Pharmacies contains a specific muvazaa assessment mechanism, and the law provides severe consequences, including cancellation of the pharmacy license and a five-year ban on opening a pharmacy.
What Is Sham Ownership in Pharmacy Law?
In general legal terms, muvazaa means a sham or simulated arrangement where the apparent legal transaction does not reflect the parties’ real intention. In pharmacy law, sham ownership usually occurs when a pharmacy is officially licensed in the name of a pharmacist, but the real owner, investor, decision-maker or profit-holder is someone else.
The most common example is the nominee pharmacist model. In this structure, a pharmacist appears as the pharmacy owner before the health authority, but a non-pharmacist investor provides the capital, controls the bank accounts, decides purchases, receives profits, hires employees or manages the pharmacy’s commercial operation. The pharmacist’s name is used to satisfy the legal requirement, while the pharmacist does not genuinely control the pharmacy.
This structure is legally dangerous because Turkish pharmacy law does not allow the professional license to be separated from real professional responsibility. The pharmacist must not be a formal cover for another person’s investment. The pharmacist must genuinely own, manage and supervise the pharmacy.
Why Sham Ownership Is Strictly Prohibited
The prohibition of sham ownership is based on public health and professional independence. Medicines are not ordinary goods. Incorrect supply, improper storage, unlawful prescription processing, controlled medicine irregularities, SGK reimbursement abuse or online sale violations may directly affect patient safety. Therefore, the law requires the pharmacy to be controlled by a pharmacist who bears professional responsibility.
Law No. 6197 also contains the one-pharmacist-one-pharmacy rule. It states that one pharmacist cannot open more than one pharmacy or assume responsible management of more than one pharmacy. This rule would become meaningless if investors could simply use different pharmacists as formal license holders for multiple pharmacies.
The anti-muvazaa system therefore protects three interests at the same time: patient safety, professional dignity and the legal pharmacy ownership structure. It prevents pharmacy chains or investor-controlled networks from being created through hidden arrangements, and it protects pharmacists from lending their professional status to unlawful commercial models.
Legal Basis of Muvazaa Sanctions
The main sanction is found in Law No. 6197. The law provides that if it is determined that a pharmacy has been opened through sham ownership, the pharmacy license is cancelled and the pharmacist cannot open a pharmacy for five years. If the sham arrangement is made between pharmacists, the opening ban applies to all pharmacists involved.
This is one of the harshest consequences in Turkish pharmacy law. License cancellation means the pharmacy loses its legal basis for operation. The five-year ban means the pharmacist cannot simply close the problematic pharmacy and open a new one immediately. Where multiple pharmacists are involved, all may be affected by the ban.
The Regulation on Pharmacists and Pharmacies also provides that if a pharmacy is found to be operated through sham ownership, or if it loses the characteristics of a pharmacy or no longer satisfies the required conditions, the provincial health directorate cancels the pharmacy license. It further states that where a pharmacy is closed due to muvazaa, the closure is implemented immediately.
Muvazaa Assessment Mechanism
The Regulation on Pharmacists and Pharmacies creates a formal muvazaa değerlendirmesi, or sham ownership assessment process. When a pharmacist applies to open or relocate a pharmacy, the provincial health directorate notifies the relevant regional chamber of pharmacists. Within fifteen business days, the regional chamber prepares a sham ownership assessment report with concrete information and documents and submits it to the provincial health directorate. The provincial health directorate then makes a decision within the regulatory period.
If either the provincial health directorate or the regional chamber of pharmacists alleges sham ownership, the matter is referred to the Muvazaa Değerlendirme Komisyonu, the Sham Ownership Assessment Commission. The commission is formed under the presidency of the provincial health director or an authorized directorate official and includes officials appointed by the provincial health directorate and the regional chamber of pharmacists.
This procedure shows that muvazaa review is not merely theoretical. It is part of the pharmacy opening and relocation process. A pharmacist applying for a new pharmacy, relocation or transfer-related operation should expect the authorities and the chamber to evaluate whether the ownership structure is genuine.
Assessment of Operating Pharmacies
Muvazaa review is not limited to new pharmacy applications. The Regulation expressly provides that if there is suspicion of sham ownership in relation to an already operating pharmacy, the assessment may be conducted through the same commission mechanism. If the commission decides that the file should be sent to the competent institution, the documents are sent for further review, and the outcome of the inspector’s examination is communicated for implementation.
This is very important in practice. A pharmacy that passed the opening stage is not permanently safe if the real ownership structure is later questioned. A dispute between investor and pharmacist, unusual bank transactions, employee statements, supplier relationships, lease structures, SGK patterns, prescription flow, accounting records or complaints may trigger a later investigation.
Therefore, sham ownership risk must be managed continuously. It is not enough to prepare a clean opening file if the pharmacy’s actual operation later shows that someone other than the pharmacist is in control.
Purpose of the Muvazaa Commission
The directive on the Sham Ownership Assessment Commission states that its purpose is to prevent free pharmacies from operating unlawfully through sham arrangements, prevent public harm and protect public health and the dignity of the pharmacy profession.
This purpose is legally significant. The issue is not only whether two private parties made a disguised contract. The state sees sham ownership as a risk to the pharmacy system itself. If a non-pharmacist investor controls the pharmacy, the pharmacist’s professional independence may be weakened, prescription ethics may be compromised, medicine supply may become purely profit-driven and public reimbursement systems may be exposed to abuse.
For this reason, the commission does not look only at the formal license. It may examine the real economic, managerial and operational structure behind the pharmacy.
Common Sham Ownership Structures
The first common structure is the capital-provider investor model. A non-pharmacist gives all the money required to open the pharmacy, pays rent, finances stock, covers renovation costs and expects to receive most or all of the profit. The pharmacist receives a fixed salary or small share while appearing as the legal owner.
The second structure is the company-controlled pharmacy model. A company cannot directly own an ordinary private pharmacy, so it places a pharmacist as the formal owner while the company controls purchasing, staff, accounting, software, bank accounts and supplier relations.
The third structure is the family front model. A family member who is not a pharmacist finances or controls the pharmacy while the pharmacist relative appears as the official owner. Family relationship does not make the structure lawful if real control does not belong to the pharmacist.
The fourth structure is the hospital or clinic-linked model. A doctor, clinic operator, hospital owner or medical tourism company indirectly controls the pharmacy and directs prescriptions to it. This creates both sham ownership and prescription referral risks.
The fifth structure is the multi-pharmacy network model. Several pharmacies appear to be owned by different pharmacists, but all are financially and operationally controlled by one investor, group or pharmacist. This may conflict with the one-pharmacist-one-pharmacy principle and anti-muvazaa rules.
Indicators of Sham Ownership
Authorities may consider many indicators when evaluating sham ownership. No single fact is always decisive, but a combination of signs may create strong suspicion.
Risk indicators may include: the pharmacist lacking sufficient financial capacity to open the pharmacy; a third party paying rent, renovation, stock or employee wages; pharmacy income being transferred to a non-pharmacist; bank accounts being controlled by another person; supplier agreements being made by a third party; the pharmacist being absent from daily operation; employees treating another person as the real boss; lease being signed or guaranteed by the investor; accounting records showing profit distribution to a non-pharmacist; or the pharmacist receiving only a fixed salary.
Other indicators include hidden loan agreements, broad consultancy contracts, management service agreements, exclusive purchasing obligations, side protocols, blank promissory notes, profit-sharing arrangements and informal WhatsApp or e-mail instructions showing that someone else manages the pharmacy.
Financing Is Not Always Sham Ownership
Not every financing relationship is automatically unlawful. A pharmacist may borrow money, receive family support, take a bank loan or lease premises with financial assistance. The legal problem arises when financing becomes control.
The distinction is this: a lawful lender expects repayment of a debt, while an unlawful hidden owner controls the pharmacy and receives business profit. A lawful landlord receives rent, while an unlawful controlling party decides how the pharmacy operates. A lawful consultant gives limited professional advice, while an unlawful controller manages stock, staff, prices, bank accounts and prescription strategy.
Therefore, pharmacy financing contracts must be drafted very carefully. Loan agreements, lease guarantees, supplier credit, family support, consultancy contracts and investment arrangements should not transfer real control away from the pharmacist. If the pharmacist is not genuinely the decision-maker, the arrangement may be treated as sham ownership.
Lease Agreements and Muvazaa Risk
Pharmacy lease agreements may create hidden ownership risk. For example, if the landlord is also the pharmacy’s financier, controls the pharmacist’s bank transactions, receives turnover-based payments far beyond ordinary rent and has the right to approve stock, employees or suppliers, the lease may be viewed as part of a sham structure.
A normal commercial lease is not prohibited. However, the lease should not make the landlord the real operator of the pharmacy. The pharmacist should retain control over pharmacy management, employees, medicine purchasing, professional decisions and patient service.
Hospital-adjacent pharmacies, shopping mall pharmacies and high-rent locations require special care. Where rent is unusually high and the pharmacist lacks financial capacity, authorities may question whether a hidden investor is behind the pharmacy. A clear and lawful lease structure helps reduce this risk.
Pharmacy Transfer and Sham Ownership
Pharmacy transfers are another high-risk area. A pharmacy may be transferred only to a legally eligible pharmacist. If a non-pharmacist investor finances the purchase and places a pharmacist as buyer on paper, the transfer may trigger sham ownership concerns.
The Regulation states that transfer of a pharmacy to another pharmacist is carried out through a report prepared in the presence of an official assigned by the provincial health directorate and an official from the chamber of pharmacists. This shows that pharmacy transfer is not only a private sale. It has an administrative and professional law dimension.
A transfer agreement should therefore show that the buyer pharmacist is the genuine acquirer. Payment source, bank records, stock transfer, lease transfer, employee transition, SGK responsibilities and control of the business should all be consistent with real pharmacist ownership.
Prescription Referral and Sham Ownership
Sham ownership often overlaps with prescription referral risk. Law No. 6197 prohibits pharmacists from cooperating openly or secretly with institutions, physicians, healthcare institutions or third parties for prescription direction; it also prohibits keeping brokers, courier personnel or similar directing staff and accepting prescriptions obtained through such methods.
A hidden investor may be a doctor, clinic owner, hospital-related business, medical tourism agency or intermediary who controls prescription flow. In such cases, the pharmacy may face two separate risks: sham ownership and unlawful prescription steering.
This is especially dangerous because prescription volume may be used as evidence of hidden commercial cooperation. If most prescriptions come through one clinic, one doctor or one intermediary, and there are financial links between that party and the pharmacy, the risk increases.
Consequences of Muvazaa Finding
The consequences are severe. Under Law No. 6197, once sham opening is determined, the license is cancelled and the pharmacist is banned from opening a pharmacy for five years. If the sham arrangement is between pharmacists, all pharmacists involved face the opening ban.
Under the Regulation, if a pharmacy is found to be operated through sham ownership, the provincial health directorate cancels the license. If the license is not returned or the pharmacist cannot be reached, the license may be cancelled from the official counterfoil. In case of closure due to sham ownership, closure is applied immediately.
These consequences may also trigger secondary problems. SGK contracts may be affected, employees may have claims, stock must be handled, lease obligations may remain, tax issues may arise and private disputes between investor and pharmacist may turn into civil or criminal proceedings.
Private Contracts May Become Unenforceable
A hidden investor may believe that a private agreement protects their investment. This is often wrong. If the agreement’s purpose is to circumvent mandatory pharmacy ownership rules, it may be unenforceable or legally risky.
For example, a contract saying “the pharmacy will be licensed in the pharmacist’s name but profits belong to the investor” may be strong evidence of sham ownership rather than protection for the investor. Similarly, side agreements transferring management control to a non-pharmacist may expose both parties to regulatory sanctions.
The pharmacist also takes a serious personal risk. Even if the investor controls the money, the license is in the pharmacist’s name. If sham ownership is found, the pharmacist may lose the license and face a five-year opening ban. The short-term financial benefit of lending the license may destroy the pharmacist’s professional future.
Administrative Procedure and Defense Rights
A pharmacist accused of sham ownership should treat the matter as an urgent administrative law dispute. The file should be reviewed carefully. The pharmacist should obtain the chamber report, commission documents, inspection findings, alleged evidence and legal basis of the claim.
A strong defense should show that the pharmacist is the genuine owner and operator. Evidence may include capital source, bank records, lease agreement, supplier contracts, accounting books, tax records, employee instructions, pharmacist presence records, stock decisions, prescription compliance procedures and proof that no third party controls the pharmacy.
If the decision is adverse, administrative and judicial remedies may be evaluated according to the type of decision, notification date and applicable procedure. Because license cancellation and five-year ban are severe consequences, deadlines must be followed strictly.
Compliance Checklist to Avoid Sham Ownership Risk
A pharmacist should apply a preventive compliance checklist before opening, transferring or relocating a pharmacy.
First, the pharmacist should prove personal financial capacity or lawful financing. Second, all funding should be documented transparently. Third, the pharmacist should control the bank accounts. Fourth, lease and supplier contracts should be in the pharmacist’s name. Fifth, employees should report to the pharmacist, not to an investor. Sixth, profit should belong to the pharmacist as the pharmacy owner. Seventh, consultancy or management agreements should not transfer control. Eighth, no non-pharmacist should decide medicine purchasing, pricing, staffing or SGK strategy.
Ninth, family support or loans should be documented as real loans, not hidden profit-sharing. Tenth, the pharmacist should be physically and professionally present in the pharmacy. Eleventh, any relationship with doctors, clinics, hospitals or medical tourism agencies should be free from prescription steering. Twelfth, all records should be consistent with genuine pharmacist ownership.
Checklist for Investors
Investors should understand that ordinary private pharmacy ownership is not an open investment field in Turkey. A non-pharmacist cannot lawfully control a pharmacy by placing a pharmacist on paper. A company cannot create a pharmacy chain by using nominee pharmacists.
Investors interested in the broader pharmaceutical sector may consider lawful alternatives such as pharmaceutical distribution, medical devices, cosmetics, regulatory consultancy, health technology, logistics or pharmaceutical company structures, subject to their own licensing rules. But private community pharmacy ownership is pharmacist-based and restrictive.
If an investor still provides financing to a pharmacist, the structure must not amount to hidden ownership. A lawful loan should be repayable as debt, not as pharmacy profit. The investor should not control daily operation, bank accounts, employees, prescriptions, SGK claims or stock.
Frequently Asked Questions
What is sham ownership in Turkish pharmacy law?
Sham ownership means a pharmacy appears to be owned by a pharmacist, but the real economic or managerial control belongs to another person, investor or company. It is legally risky because private pharmacies must be genuinely owned and professionally managed by pharmacists.
What happens if a pharmacy is found to be opened through sham ownership?
The pharmacy license is cancelled, and the pharmacist cannot open a pharmacy for five years. If the sham arrangement is between pharmacists, the opening ban applies to all involved pharmacists.
Is muvazaa checked only during opening?
No. The Regulation provides a sham ownership assessment mechanism for opening and relocation applications, but it also allows assessment of already operating pharmacies where suspicion exists.
Can a non-pharmacist finance a pharmacy?
Financing alone is not always sham ownership, but if the financier controls profit, bank accounts, employees, stock, management or prescription flow, the structure may be considered sham ownership.
Can pharmacists make business partnerships with non-pharmacists?
Any structure that gives a non-pharmacist real control over a private pharmacy is highly risky. Contracts should not separate formal pharmacist ownership from actual economic and operational control.
Conclusion
Sham ownership in Turkish pharmacy law is one of the most serious compliance risks for pharmacies. Turkish law requires private pharmacies to be genuinely opened and operated by pharmacists. A pharmacist cannot merely lend their name or license to a non-pharmacist investor, company, clinic, landlord, family member or business group.
The legal consequences are severe. Law No. 6197 provides that if sham ownership is detected, the pharmacy license is cancelled and the pharmacist is banned from opening a pharmacy for five years. Where the sham arrangement is between pharmacists, the ban applies to all involved pharmacists. The Regulation on Pharmacists and Pharmacies also provides a detailed assessment mechanism involving the regional chamber of pharmacists, provincial health directorate and Muvazaa Değerlendirme Komisyonu.
For pharmacists, the safest approach is genuine ownership, transparent financing, personal professional supervision and consistent records. The pharmacist should control the pharmacy’s bank accounts, employees, stock, purchasing, SGK processes and professional decisions. For investors, the key lesson is that Turkish private pharmacy ownership cannot be structured like ordinary retail investment.
A legally secure pharmacy must be built on real pharmacist responsibility, not paper ownership. In Turkey, the pharmacy license is not a commercial mask; it is a professional public health responsibility. Sham ownership may seem profitable in the short term, but it can lead to license cancellation, professional exclusion, financial collapse and serious legal disputes.
Yanıt yok